Friday, July 5, 2024

I'm Dr. Sabine Hazan.  I'm a gastroenterologist by trade.  I have been doing clinical trials for pharmaceutical companies for almost three decades.  I'm not here to shake the beehive of the FDA.  I'm here to make sure that the FDA is doing what it's supposed to do, which is assuring my safety and the safety of millions of Americans who are paying taxes.  Because I spearhead the microbiome research, I started paying attention because of the genetic sequence of the virus.  And we kind of joined forces with a lot of doctors in America and when we collected stool samples we noticed a whole sequence of COVID in the stools.  We basically started analyzing what is the best combination therapy to put out.  Some of the doctors are saying, you know, vitamin C seems to be working in Italy.  Then the protocol of Didier Raoul came out.  Hydroxychloroquine was interesting because, after millions of prescriptions, we've never had any problems as azithromycin was another good solution and zinc certainly seemed plausible.  I said I bet you hydroxychloroquine and azithromycin kill the virus, and then vitamin C, vitamin D, and zinc increase the microbiome.  Right when we found the whole genome of COVID in the stools, we discovered that two people who were on hydroxychloroquine and Z-Pak didn't have the virus anymore.  So I started writing the protocol sometime in March and the FDA says you don't need to do a clinical trial proceed and that was like April 3rd.  A couple days later, they said, "I'm sorry, Dr. Hazan, you have to do a full-on clinical trial.  My protocol was seen by a lot of doctors on clinicaltrials.gov.  April 13, 2020, I got a letter from the Gates Foundation, and here's the quote

We are helping W.H.O., the World Health Organization, to track and monitor clinical trials evaluating pre exposure prophylaxis of healthcare workers.  We are especially interested in those studies using either chloroquine or hydroxychloroquine .

Right?  Wasn't that interesting? 

The World Health Organization

No comments:

Post a Comment